EMBL Australia works with a range of Australian and international research organisations to achieve its mission.
The Australian Regenerative Medicine Institute is a state-of-the-art research facility established by a joint venture between Monash University and the Government of Victoria.
Research focuses on unraveling basic mechanisms underlying the regenerative process, which will enable physicians to prevent, halt and reverse damage to vital organs due to disease, injury or genetic conditions. This research will form the basis of treatments for conditions such as neurodegenerative disorders, type 1 diabetes, arthritis, musculo-skeletal and cardiovascular diseases.
Building on and enhancing existing Monash University expertise in stem cell, developmental and structural biology, ARMI integrates research in three key platforms:
- structural biology (molecular level)
- cell biology (cell level)
- regenerative biology (organism level)
The Australian Genome Research Facility Ltd (AGRF) was established in 1997 as part of the Commonwealth Government's Major National Research Facility (MNRF) Program and operates out of five nodes in each major Australian capital city. AGRF, a not for profit company, is Australia's largest provider of genomics services and solutions. AGRF has laboratories in Brisbane, Sydney, Melbourne, Adelaide and Perth, each providing a gateway to a national network of state-of-the-art facilities, technology and expertise.
From microbes to plants, animals and humans, AGRF provides a full range of services across the entire biological spectrum, including academia and industry with clients from bioscience, environmental science, biomedicine and agricultural biotechnology.
The Australian Microscopy and Microanalysis Research Facility (AMMRF) aims to further support collaboration and resource-sharing in the scientific community.
AMMRF have expertise in microscopy and microanalysis that provides nano structural characterisation capability and services, including widely used optical, electron, X-ray and ion-beam techniques and world-leading flagship platforms.
The Australian Nuclear Science and Technology Organisation (ANSTO) began in 1949 as an industrial committee composed of scientific and Government representatives. The committee's aim was to examine possible industrial applications for nuclear technology and to suggest a national program for atomic research.
Today, ANSTO is public research organisation within the portfolio of the Commonwealth Department Industry and Science. ANSTO is responsible for delivering world-class research and innovation in nuclear science and technology to government, industry, academia and other research organisations. It does so through the development of new knowledge, delivery of quality services and support for business opportunities.
The Australian Phenomics Facility (APF) helps researchers at EMBL Australia develop, characterise and archive new mouse models of human disease.
BioGrid Australia Limited is a secure research platform and infrastructure that provides access to real-time clinical, imaging and biospecimen data across jurisdictions, institutions and diseases. The web-based platform provides ethical access while protecting both privacy and intellectual property.
As modern research and planning becomes more complex, the need for collaboration in research significantly increases. The web-based platform has the capacity to uniquely identify and ethically integrate data collected about a consumer across multiple institutions.
BioGrid also has the capability to link data with other data sets, produce tailored reports for auditing and reporting and provide statistical analysis tools to conduct more advanced research analysis. Authorised users can access, transform and add to data and test research questions using their own analytical tools or those made available by BioGrid.
BioGrid Australia provides a flexible and secure method for interrogating the multiple data sources, where thousands of records of patient data is record-linked across all the databases and institutions.
Bioplatforms Australia was established in 2007 under the National Collaborative Research Infrastructure Strategy (NCRIS) to manage a Commonwealth Government investment in the rapidly-expanding ‘-omics’ disciples.
Bioplatforms Australia acts as a co-ordinating body for four ‘omics consortiums that offer world class expertise and host state-of-the-art facilities and infrastructure:EMBL Australia and Bioplatforms Australia have an agreement for EMBL Australia research teams to access key research facilities operated through the Bioplatforms Australia network.
- Genomics Australia: specialise in high throughput gene sequencing, transcript analysis, epigenetics, bioinformatics
- Proteomics Australia: specialist services for protein separation, mass spectrometry, monoclonal antibody development, protein chemistry
- Metabolomics Australia: specialise in small molecule analysis, sample preparation, metabolite profiling, mass spectrometry
- Australian Bioinformatics Facility: offers cutting edge computational tools and strategies for experiment planning, data acquisition, data analysis, data reporting.
The South Australian Health and Medical Research Institute (SAHMRI) is South Australia’s first independent, flagship health and medical research institute and the pioneer of the state’s new Health and Biomedical Precinct on North Terrace in Adelaide.
The Institute will house a mix of 600 South Australian, interstate and international researchers in its purpose built, iconic building – a symbol of a growing, vibrant Adelaide. The facility has been a key element in attracting new research talent and retaining the best from within SA. SAHMRI will support and foster an environment where early career researchers can build their careers and undertake world-leading research.
SAHMRI has established seven research themes: Aboriginal Health, Cancer, Healthy Mothers, Babies and Children, Heart Health, Infection and Immunity, Mind and Brain, Nutrition and Metabolism.
As part of its commitment to translation and conducting research across the research spectrum, SAHMRI has created Pillar Committees based on the four pillars of health and medical research:
- Clinical Research and Drug & Device Development
- Health Services Research
- Population Health and Health & Social Policy.
Each Pillar Committee comprises members of the health and medical research community with extensive experience who will engage with SAHMRI’s research themes and promote cross-disciplinary research. Each pillar intersects with each of SAHMRI’s research themes and links with the other pillars in order to achieve translational health outcomes.
UNSW’s Single Molecule Science initiative focuses on transforming medicine by providing a molecular perspective on complex biological systems and processes, encompassing biophysics, biochemistry and cell biology as well as nanotechnology and nanofabrication.
This work is underpinned by the new imaging and analysis technologies being developed by Professor Katharina Gaus, group leader at the Centre for Vascular Research at the Lowy Cancer Research Centre and Deputy Director of the ARC Centre of Excellence in Advanced Molecular Imaging.
It also includes the UNSW Centre in Single Molecule Science, which is a new node of EMBL Australia based at UNSW’s Lowy Cancer Research Centre.